The intravenous injections of the PD-L1 antibodies were even more lethal, as 9/10 of the tumor-bearing mice receiving 200 μg antibody per injection had died within two weeks after injection, with significant reductions in weight gains. This evidence concerns the gene CD274 and neoplasm.